NEWS
April 3-6, 2023: Aviex Technologies LLC Participating in the World Vaccine Congress
Aviex Technologies LLC will be participating in the World Vaccine Congress in Washington DC. Aviex will be setting appointments for Partnership discussions at this event. Please see the contact page for ongoing conversation.
February 27, 2023: New Publication
The third publication on the Aviex drug candidate for Schistosomiasis mansoni was published by NPJ: VACCINE.
Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice
Adam S. Hassan, Se'bastien Houle, Lydia Labrie, Dilhan J. Perera, Charles M. Dozois, Brian J. Ward & Momar Ndao
Department of Microbiology and immunology, McGill University Montreal, Quebec, Canada
February 19, 2023: Update to the Board of Directors
Aviex Technologies LLC announced today that Garrett Bowden, Director of Business Development and SusAnna Bernard-Grae, Secretary of the Company, have been appointed to the Board of Directors.